Last 12 months
Inside the activity.
0 purchase rows · 48 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 12 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2023 Filed Apr 5, 2023 00:10 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
GrantCommon Stock | 63,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041742 · tm2311710-9_4seq1.xml · nonDerivative · entry 2 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,056 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 28, 2023 Filed Apr 5, 2023 00:10 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
GrantCommon Stock | 95,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041742 · tm2311710-9_4seq1.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,370 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023. Read SEC document |
| February 28, 2023 Filed Apr 5, 2023 00:08 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
GrantCommon Stock | 11,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041740 · tm2311710-8_4seq1.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,407 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 28, 2023 Filed Apr 5, 2023 00:08 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
GrantCommon Stock | 17,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041740 · tm2311710-8_4seq1.xml · nonDerivative · entry 1 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,829 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023. Read SEC document |
| February 28, 2023 Filed Apr 5, 2023 00:07 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
GrantCommon Stock | 11,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041738 · tm2311710-7_4seq1.xml · nonDerivative · entry 2 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,607 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 28, 2023 Filed Apr 5, 2023 00:07 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
GrantCommon Stock | 17,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041738 · tm2311710-7_4seq1.xml · nonDerivative · entry 1 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,029 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023. Read SEC document |
| February 28, 2023 Filed Apr 5, 2023 00:06 UTC |
Marken James G.SVP OPS & PROD DEV
|
GrantCommon Stock | 8,684 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041737 · tm2311710-6_4seq1.xml · nonDerivative · entry 2 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,916 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 28, 2023 Filed Apr 5, 2023 00:06 UTC |
Marken James G.SVP OPS & PROD DEV
|
GrantCommon Stock | 13,026 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041737 · tm2311710-6_4seq1.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,232 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023. Read SEC document |
| February 28, 2023 Filed Apr 5, 2023 00:04 UTC |
Gutwerg OriSVP, GENERICS
|
GrantCommon Stock | 11,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041734 · tm2311710-5_4seq1.xml · nonDerivative · entry 2 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,974 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 28, 2023 Filed Apr 5, 2023 00:04 UTC |
Gutwerg OriSVP, GENERICS
|
GrantCommon Stock | 17,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041734 · tm2311710-5_4seq1.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,396 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023. Read SEC document |
| February 28, 2023 Filed Apr 5, 2023 00:01 UTC |
Davis KristaSVP, CHIEF HR OFFICER
|
GrantCommon Stock | 8,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041721 · tm2311710-3_4seq1.xml · nonDerivative · entry 2 Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,695 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 28, 2023 Filed Apr 5, 2023 00:01 UTC |
Davis KristaSVP, CHIEF HR OFFICER
|
GrantCommon Stock | 12,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041721 · tm2311710-3_4seq1.xml · nonDerivative · entry 1 Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,591 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023. Read SEC document |
| February 28, 2023 Filed Apr 5, 2023 00:03 UTC |
Gassert ChadSVP - CORP. DEV. & STRATEGY
|
GrantCommon Stock | 11,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041729 · tm2311710-4_4seq1.xml · nonDerivative · entry 2 Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,947 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 28, 2023 Filed Apr 5, 2023 00:03 UTC |
Gassert ChadSVP - CORP. DEV. & STRATEGY
|
GrantCommon Stock | 17,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041729 · tm2311710-4_4seq1.xml · nonDerivative · entry 1 Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,369 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023. Read SEC document |
| February 28, 2023 Filed Apr 5, 2023 00:00 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
GrantCommon Stock | 8,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041716 · tm2311710-2_4seq1.xml · nonDerivative · entry 2 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,542 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 28, 2023 Filed Apr 5, 2023 00:00 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
GrantCommon Stock | 12,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041716 · tm2311710-2_4seq1.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,438 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023. Read SEC document |
| February 28, 2023 Filed Apr 7, 2023 00:00 UTC |
CAREY STEPHEN P.SVP & CFO
|
GrantCommon Stock | 16,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-042847 · tm2311710-1_4seq1.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,012 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 28, 2023 Filed Apr 7, 2023 00:00 UTC |
CAREY STEPHEN P.SVP & CFO
|
GrantCommon Stock | 24,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-042847 · tm2311710-1_4seq1.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,802 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:32 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
Tax withholdingCommon Stock | 1,292 | $45.04 | $58,191.68 |
DisclosureSEC source: 0001104659-23-023305 · tm237192-2_4seq1.xml · nonDerivative · entry 1 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,562 Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:31 UTC |
Gutwerg OriSVP, GENERICS
|
Tax withholdingCommon Stock | 1,275 | $45.04 | $57,426.00 |
DisclosureSEC source: 0001104659-23-023303 · tm237192-1_4seq1.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,369 Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 21:00 UTC |
MERIDIAN VENTURE PARTNERS II LP10% owner
Meridian Venture Partners II, Co.10% owner
Brown Robert E. JRDirector
|
SaleCommon Stock | 200,000 | $38.50 | $7,700,000.00 |
DisclosureSEC source: 0001104659-22-124079 · tm2231885-1_4.xml · nonDerivative · entry 1 MERIDIAN VENTURE PARTNERS II LP · CIK 0001109507 · 10% owner Meridian Venture Partners II GP, L.P. · CIK 0001580170 · 10% owner Meridian Venture Partners II, Co. · CIK 0001580169 · 10% owner Brown Robert E. JR · CIK 0001579672 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,019,259 F1 · shares: Meridian Venture Partners II, L.P. sold the shares that are the subject of this Form 4 for its liquidity purposes, and no additional sales are planned at this time. Read SEC document |
| September 12, 2022 Filed Sep 14, 2022 23:06 UTC |
Davis KristaSVP, CHIEF HR OFFICER
|
GrantCommon Stock | 16,433 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-009623 · form4-09142022_040950.xml · nonDerivative · entry 1 Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,433 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of September 12, 2022. Read SEC document |
| September 08, 2022 Filed Sep 13, 2022 00:15 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 3,646 | $37.61 | $137,126.06 |
DisclosureSEC source: 0001415889-22-009569 · form4-09122022_050932.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,957 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 7,127 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 01:01 UTC |
Marken James G.SVP OPS & PROD DEV
|
SaleCommon Stock | 5,172 | $37.79 | $195,463.84 |
DisclosureSEC source: 0001415889-22-008738 · form4-08162022_060804.xml · nonDerivative · entry 2 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,642 F2 · price: The shares were sold in multiple trades at prices ranging from $37.70 to $38.00. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 12, 2022 Filed Aug 17, 2022 01:01 UTC |
Marken James G.SVP OPS & PROD DEV
|
SaleCommon Stock | 12,894 | $37.04 | $477,605.36 |
DisclosureSEC source: 0001415889-22-008738 · form4-08162022_060804.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,814 F1 · price: The shares were sold in multiple trades at prices ranging from $37.01 to $37.295. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 18, 2022 Filed Jul 20, 2022 20:48 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
GrantCommon Stock | 19,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-007848 · form4-07202022_010706.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,280 F1 · acquired: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of July 18, 2022. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 22:38 UTC |
Gutwerg OriSVP, GENERICS
|
GrantCommon Stock | 6,476 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004412 · form4-04292022_030449.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,644 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 22:37 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
GrantCommon Stock | 6,476 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004411 · form4-04292022_030430.xml · nonDerivative · entry 1 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,854 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 22:35 UTC |
Marken James G.SVP OPS & PROD DEV
|
GrantCommon Stock | 6,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004408 · form4-04292022_030410.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,708 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 22:34 UTC |
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFO
|
GrantCommon Stock | 11,291 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004405 · form4-04292022_030455.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,633 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 22:32 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
GrantCommon Stock | 33,352 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004403 · form4-04292022_030445.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,603 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 22:31 UTC |
HAUGHEY THOMASDirector
|
GrantCommon Stock | 10,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004401 · form4-04292022_030452.xml · nonDerivative · entry 1 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,251 F1 · kind: Represents a restricted stock award that will vest in full on April 27, 2023. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 22:28 UTC |
NASH DAVIDDirector
|
GrantCommon Stock | 10,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004398 · form4-04292022_030424.xml · nonDerivative · entry 1 NASH DAVID · CIK 0001251968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,696 F1 · kind: Represents a restricted stock award that will vest in full on April 27, 2023. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 22:27 UTC |
Pera Antonio RDirector
|
GrantCommon Stock | 10,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004396 · form4-04292022_030409.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,762 F1 · kind: Represents a restricted stock award that will vest in full on April 27, 2023. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 22:26 UTC |
Thoma JeanneDirector
|
GrantCommon Stock | 10,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004394 · form4-04292022_030449.xml · nonDerivative · entry 1 Thoma Jeanne · CIK 0001819879 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,334 F1 · kind: Represents a restricted stock award that will vest in full on April 27, 2023. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 22:24 UTC |
Walsh Patrick DDirector
|
GrantCommon Stock | 10,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004393 · form4-04292022_030412.xml · nonDerivative · entry 1 Walsh Patrick D · CIK 0001720568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,437 F1 · kind: Represents a restricted stock award that will vest in full on April 27, 2023. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 22:23 UTC |
Brown Robert E. JRDirector
|
GrantCommon Stock | 10,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004392 · form4-04292022_030457.xml · nonDerivative · entry 1 Brown Robert E. JR · CIK 0001579672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,021 F1 · kind: Represents a restricted stock award that will vest in full on April 27, 2023. Read SEC document |
| April 10, 2022 Filed Apr 12, 2022 21:13 UTC |
Marken James G.SVP OPS & PROD DEV
|
Tax withholdingCommon Stock | 1,878 | $29.91 | $56,170.98 |
DisclosureSEC source: 0001415889-22-004022 · form4-04122022_020409.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,064 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,137 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| April 10, 2022 Filed Apr 12, 2022 21:11 UTC |
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFO
|
Tax withholdingCommon Stock | 4,534 | $29.91 | $135,611.94 |
DisclosureSEC source: 0001415889-22-004020 · form4-04122022_020415.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,342 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 9,942 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:37 UTC |
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFO
|
Tax withholdingCommon Stock | 912 | $29.69 | $27,077.28 |
DisclosureSEC source: 0001415889-22-003970 · form4-04082022_020427.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,876 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 2,000 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:36 UTC |
Marken James G.SVP OPS & PROD DEV
|
Tax withholdingCommon Stock | 337 | $29.69 | $10,005.53 |
DisclosureSEC source: 0001415889-22-003968 · form4-04082022_020452.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,942 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,100 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 20:13 UTC |
Marken James G.SVP OPS & PROD DEV
|
Tax withholdingCommon Stock | 524 | $28.17 | $14,761.08 |
DisclosureSEC source: 0001415889-22-003472 · form4-03302022_010359.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,279 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,712 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 20:10 UTC |
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFO
|
Tax withholdingCommon Stock | 1,420 | $28.17 | $40,001.40 |
DisclosureSEC source: 0001415889-22-003471 · form4-03302022_010309.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,788 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,113 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 24, 2022 Filed Mar 29, 2022 00:51 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
GrantCommon Stock | 19,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-003396 · form4-03282022_050322.xml · nonDerivative · entry 1 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,378 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022. Read SEC document |
| March 24, 2022 Filed Mar 29, 2022 00:50 UTC |
Gutwerg OriSVP, GENERICS
|
GrantCommon Stock | 19,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-003395 · form4-03282022_050327.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,168 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022. Read SEC document |
| March 24, 2022 Filed Mar 29, 2022 00:49 UTC |
Marken James G.SVP OPS & PROD DEV
|
GrantCommon Stock | 19,934 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-003394 · form4-03282022_050305.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,803 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022. Read SEC document |
| March 24, 2022 Filed Mar 29, 2022 00:48 UTC |
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFO
|
GrantCommon Stock | 33,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-003393 · form4-03282022_050357.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,208 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022. Read SEC document |
| March 24, 2022 Filed Mar 29, 2022 00:46 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
GrantCommon Stock | 100,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-003392 · form4-03282022_050347.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,251 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022. Read SEC document |
| March 23, 2022 Filed Mar 26, 2022 00:56 UTC |
Marken James G.SVP OPS & PROD DEV
|
Tax withholdingCommon Stock | 2,452 | $27.03 | $66,277.56 |
DisclosureSEC source: 0001415889-22-003382 · form4-03252022_050339.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,869 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 8,010 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 23, 2022 Filed Mar 26, 2022 00:53 UTC |
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFO
|
Tax withholdingCommon Stock | 4,167 | $27.03 | $112,634.01 |
DisclosureSEC source: 0001415889-22-003381 · form4-03252022_050310.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,333 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 13,617 shares of restricted stock, the grant of which was previously reported. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.